| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
49,623 | 50,451 | 33,363 | 21,162 | 20,675 |
| Cost of Revenue
|
-9,228 | -10,029 | -9,260 | -4,069 | -3,992 |
|
Gross Profit
|
40,395 | 40,422 | 24,103 | 17,093 | 16,683 |
| Selling, General and Administrative Expenses
|
-13,471 | -16,304 | -12,238 | -5,425 | -4,546 |
|
Research and Development Expenses
|
0 | -21 | 0 | -139 | -98 |
| Depreciation, Amortization and Depletion
|
-7,195 | -7,232 | -4,017 | -1,227 | -989 |
|
Operating Income/Expenses
|
-20,666 | -23,557 | -16,255 | -6,791 | -5,633 |
|
Total Operating Profit/Loss
|
19,729 | 16,865 | 7,848 | 10,302 | 11,050 |
| Total Net Finance Income/Expense
|
-386 | -1,165 | 330 | 1,870 | 464 |
| Net Investment Income
|
-1,583 | 1,685 | -2,508 | 778 | -35 |
| Irregular Income/Expenses
|
-296 | -222 | -2,715 | -269 | 0 |
|
Non-Operating Income/Expenses, Total
|
-2,265 | 298 | -4,893 | 2,379 | 429 |
|
Pretax Income
|
17,464 | 17,163 | 2,955 | 12,681 | 11,479 |
| Provision for Income Tax
|
11,524 | 10,166 | 8,590 | 7,702 | 15,157 |
|
Net Income from Continuing Operations
|
28,988 | 27,329 | 11,545 | 20,383 | 26,636 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
28,988 | 27,329 | 11,545 | 20,383 | 26,636 |
|
Net Income after Non-Controlling/Minority Interests
|
28,988 | 27,329 | 11,545 | 20,383 | 26,636 |
|
Net Income Available to Common Stockholders
|
28,988 | 27,329 | 11,545 | 20,383 | 26,636 |
|
Diluted Net Income Available to Common Stockholders
|
28,988 | 27,329 | 11,545 | 20,383 | 26,636 |
| Basic EPS
|
1.14 | 1.07 | 0.47 | 0.82 | 1.05 |
| Diluted EPS
|
1.11 | 1.05 | 0.46 | 0.80 | 1.03 |
|
Basic Weighted Average Shares Outstanding
|
25,355.52 | 25,483.65 | 24,721 | 25,004.84 | 25,376.29 |
|
Diluted Weighted Average Shares Outstanding
|
25,826.62 | 25,989.09 | 25,221.89 | 25,422.20 | 25,799.16 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
17,850 | 18,328 | 2,625 | 10,811 | 11,015 |
|
EBITDA
|
25,045 | 25,560 | 6,642 | 12,038 | 12,004 |
|
Normalized EBITDA
|
28,609 | 25,835 | 12,937 | 12,719 | 12,442 |
|
Normalized Income
|
32,017.40 | 27,562.75 | 16,895.75 | 20,885.51 | 26,959.20 |
|
Total Unusual Items
|
3,564 | 275 | 6,295 | 681 | 438 |
|
Total Unusual Items Excluding Goodwill
|
3,564 | 275 | 6,295 | 681 | 438 |
12/31/2022 - 5/7/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade